The University of Strathclyde has partnered with US firm Korrus to lead the patent licensing for its groundbreaking HINS light technology (High Intensity Narrow Spectrum).

A research team at the university developed the system that decontaminates the air and exposed surfaces safely in the presence of humans, preventing the spread of dangerous infections.

Synergy between HINS-light technology and the recent work of Korrus was recognised by the parties who have been working together to provide a patent pool for one-stop licensing.

Korrus is focused on Human Light Interaction (HLI) and the partnership with Strathclyde is designed to aid a streamlined, global adoption of the visual light disinfection tech. It will see all future worldwide antibacterial lighting patent licensing efforts led by Korrus.

Professor Scott MacGregor, Vice-Principal of the University of Strathclyde, and leader of the HINS-light research team said: “The university seeks to forge meaningful partnerships with organisations across the world and this latest partnership with Korrus builds on our many years of research and development of HINS-light.

“To bring novel, light-based products to market at global scale is exciting and together we look forward to paving the way to mass adoption of much-needed visible light disinfection products.”

Recommended

• Leader Insights | Is a CPTO right for you?
• Work begins on BT’s new Dundee development
• Scottish startup Stamp Free raises £600k

The innovative HINS-light technology can deactivate harmful bacteria such as MRSA in the air and on surfaces using a narrow spectrum of visible light. The light-based disinfection method operates at a wavelength and provides significantly greater reductions of bacterial pathogens in the environment than can be achieved by conventional cleaning.

The discovery signalled a huge step forward in the ability to prevent the spread of infection and after many trials in the healthcare sector over the last 15 years the university has entered into several licence agreements across the globe.

Korrus CEO Mark Reynoso said: “At Korrus, we recognised that the best solution to opening the market requires a broad licensing strategy built around both Korrus patents and the University of Strathclyde patents.

“Through this partnership, we can now offer a comprehensive licensing programme around antimicrobial lighting technologies, to help to reduce illness and disease caused by bacteria and fungi.”

Get the latest news from DIGIT direct to your inbox

Our newsletter covers the latest technology and IT news from Scotland and beyond, as well as in-depth features and exclusive interviews with leading figures and rising stars.

To subscribe, click here.